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MYC is one of the most commonly mutated and highly amplified oncogenes in human breast cancer. 
MYC amplifications occur most frequently in triple-negative breast cancers (TNBCs). TNBCs can be 
divided into two molecular subtypes: basal-like and claudin-low breast cancers. These cancers tend 
to be extremely aggressive and are strongly associated with disease recurrence, poor prognosis and 
high mortality. In particular, claudin-low tumors are classified by a loss of tight junctions and cell-to-
cell contacts and an enrichment for genes associated with an epithelial-to-mesenchymal transition 
(EMT) and mammary stem cells (also known as tumor-initiating cells). Despite the high level of 
disease severity, there are no targeted therapies for claudin-low TNBCs. To address this unmet need, 
we utilized human mammary epithelial cells (HuMECs) that express oncogenic levels of MYC and a 
mutant MYC (T58A) to characterize the behavioral and metabolic changes that occur during the 
formation of MYC-driven breast cancers. We found that MYC regulates the expression of genes 
associated with cell stemness, EMT, lipid metabolism, and calcium (Ca2+) signaling and that the 
expression of this gene signature promotes cell growth, survival, migration, and metabolic plasticity. 
The gene signature of MYC-expressing HuMECs highly correlates with the gene signature of claudin-
low breast cancers, therefore highlighting the relevance of our HuMEC model to human claudin-low 
breast cancer. We found the major drivers underlying the MYC-dependent changes in cell behavior 
to be stimulation of Ca2+ signaling and strong activation of lipid metabolism. Ca2+ signaling is 
stimulated through the MYC-dependent repression of Ca2+ efflux mechanisms; elevated cytosolic 
Ca2+ then consequently stimulates a Ca2+/calmodulin kinase kinase 2 (CAMKK2)/AMPK signaling 
ĂǆŝƐƚŚĂƚĂĐƚŝǀĂƚĞƐĨĂƚƚǇĂĐŝĚƐĐĂǀĞŶŐŝŶŐĂŶĚƚƌĂŶƐƉŽƌƚ ?ĂƐǁĞůůĂƐɴ-oxidation. Enhanced lipid 
metabolism thereby provides the necessary biomass (fatty acids) for phospholipid biosynthesis and 
energy (ATP) to support the metabolically demanding processes of cell growth, proliferation, and 
migration. In all, our findings provide a strong rationale for targeting lipid metabolism and the 
Ca2+/CAMKK2/AMPK signaling axis in MYC-driven, and potentially claudin-low, breast cancers. 
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